MiR-191 as a Key Molecule in Aneurysmal Aortic Remodeling.

abdominal aortic aneurysms endothelial dysfunction microRNA

Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
30 10 2021
Historique:
received: 17 08 2021
revised: 01 10 2021
accepted: 05 10 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 13 1 2022
Statut: epublish

Résumé

Abdominal aortic aneurysms (AAA) are a complex disease with an unclear pathomechanism. A positive family history is emphasized as a significant risk factor, and a nonspecific model of inheritance suggests participation of epigenetic regulation in the pathogenesis of this disease. Past studies have implicated microRNAs in the development of AAA; therefore in this project, we measured miR-191 levels in AAA patients and compared them with a control group. We found that miR-191 levels were significantly elevated in aneurysmal patients, although this did not correlate with the available clinical data. We then developed an in vitro model where, using cells with an endothelial phenotype, we determined the effect of miR-191 on the transcriptome using RNA sequencing. Subsequent pathway analysis established that some of the perturbations mediated by miR-191 can be explained by several processes which have long been observed and described in literature as accompanying the development of abdominal aortic aneurysms.

Identifiants

pubmed: 34827608
pii: biom11111611
doi: 10.3390/biom11111611
pmc: PMC8615628
pii:
doi:

Substances chimiques

MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Circ Res. 2019 Feb 15;124(4):607-618
pubmed: 30763207
Atherosclerosis. 2019 Oct;289:14-20
pubmed: 31445353
J Biomed Res. 2014 Jan;28(1):47-52
pubmed: 24474963
Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2429-38
pubmed: 25234817
Ann Vasc Surg. 2018 Jul;50:209-217
pubmed: 29518510
Circulation. 2008 Jan 15;117(2):242-52
pubmed: 18195185
Nat Genet. 2003 Mar;33(3):407-11
pubmed: 12598898
Circulation. 2005 Jul 26;112(4):513-20
pubmed: 16027248
Circ Res. 2005 Nov 25;97(11):1093-107
pubmed: 16306453
Circulation. 2011 Dec 20;124(25):e906-12
pubmed: 22184047
Nat Genet. 2003 Mar;33 Suppl:245-54
pubmed: 12610534
Front Immunol. 2019 Sep 04;10:1979
pubmed: 31552015
J Biol Chem. 2016 Nov 4;291(45):23532-23544
pubmed: 27634043
Science. 2006 Apr 7;312(5770):117-21
pubmed: 16601194
Nat Rev Genet. 2015 Jul;16(7):421-33
pubmed: 26077373
Heart. 2006 Jan;92(1):137-42
pubmed: 16365370
Lancet. 2005 Apr 30-May 6;365(9470):1577-89
pubmed: 15866312
Clin Biochem. 2015 Oct;48(15):988-92
pubmed: 25916817
Nat Commun. 2019 Nov 6;10(1):5046
pubmed: 31695038
Nat Rev Genet. 2013 Aug;14(8):535-48
pubmed: 23817310
Stem Cell Reports. 2016 Mar 8;6(3):292-301
pubmed: 26876669
Ann Thorac Surg. 2016 Oct;102(4):1245-52
pubmed: 27234576
Nat Rev Cardiol. 2017 Apr;14(4):197-208
pubmed: 28102232
Pharmacol Rep. 2015 Apr;67(2):376-81
pubmed: 25712667
Biochem Biophys Res Commun. 2012 Jul 6;423(3):509-14
pubmed: 22683624
Int J Oncol. 2012 Oct;41(4):1305-13
pubmed: 22843066
Ann R Coll Surg Engl. 2014 Sep;96(6):405-14
pubmed: 25198969
Trends Cell Biol. 2015 Oct;25(10):601-610
pubmed: 26410406
J Hematol Oncol. 2018 Aug 23;11(1):107
pubmed: 30139373
J Vasc Surg. 2009 Oct;50(4):880-96
pubmed: 19786241
Curr Mol Med. 2011 Mar;11(2):93-109
pubmed: 21342132
J Vasc Res. 2020;57(4):236-244
pubmed: 32434199
J Pathol. 2009 May;218(1):131-42
pubmed: 19224541
Nat Rev Genet. 2015 Feb;16(2):71-84
pubmed: 25554358
Exp Clin Cardiol. 2011 Spring;16(1):11-5
pubmed: 21523201
Circulation. 2001 Jul 17;104(3):304-9
pubmed: 11457749
Int J Biol Sci. 2013 Nov 09;9(10):1057-69
pubmed: 24250251

Auteurs

Sabina Lichołai (S)

Division of Molecular Biology and Clinical Genetics, Faculty of Medicine, Jagiellonian University Medical College, Skawinska 8, 31-066 Kraków, Poland.

Dorota Studzińska (D)

Department of Intensive Care and Perioperative Medicine, Faculty of Medicine, Jagiellonian University Medical College, Wrocławska 1/3, 30-901 Kraków, Poland.

Hanna Plutecka (H)

Division of Molecular Biology and Clinical Genetics, Faculty of Medicine, Jagiellonian University Medical College, Skawinska 8, 31-066 Kraków, Poland.

Tomasz Gubała (T)

Sano Centre for Computational Medicine, Czarnowiejska 36, 30-054 Kraków, Poland.

Wojciech Szczeklik (W)

Department of Intensive Care and Perioperative Medicine, Faculty of Medicine, Jagiellonian University Medical College, Wrocławska 1/3, 30-901 Kraków, Poland.

Marek Sanak (M)

Division of Molecular Biology and Clinical Genetics, Faculty of Medicine, Jagiellonian University Medical College, Skawinska 8, 31-066 Kraków, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH